Discrepant expression of cytokines in inflammation- And age-related cataract patients

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Chen, Wan ^a   Lin, Haotian ^a   Zhong, Xiaojian ^a   Liu, Zhaochuan ^a   Geng, Yu ^a   Xie, Chufang ^a   Chen, Weirong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; CYTOKINE;

ANALYTIC METHOD; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; ARTICLE; BEHCET DISEASE; CATARACT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INFLAMMATION; INFLAMMATORY CATARACT; INFLAMMATORY CELL; LASER FLARE CELL METER; LEUKOCYTE CULTURE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENILE CATARACT; VOGT KOYANAGI SYNDROME; ADULT; BLOOD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; ANTERIOR CHAMBER; AQUEOUS HUMOR; CATARACT; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED;

EID: 84907833433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109647     Document Type: Article

References (27)

1. O'Shea JJ, Ma A, Lipsky P (2002) Cytokines and autoimmunity. Nat Rev Immunol 2: 37-45.
2. Zhou ZY, Chen SL, Shen N, Lu Y (2012) Cytokines and Behcet's disease. Autoimmunity reviews 11: 699-704.
3. Damico FM, Bezerra FT, Silva GC, Gasparin F, Yamamoto JH (2009) New insights into Vogt-Koyanagi-Harada disease. Arq Bras Oftalmol 72: 413-420.
4. Imai Y, Ohno S (2002) Helper T-cell subsets in uveitis. Int Ophthalmol Clin 42: 25-32.
5. Lohmann T, Laue S, Nietzschmann U, Kapellen TM, Lehmann I, et al. (2002) Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes 51: 2474-2480.
6. Jager A, Kuchroo VK (2010) Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 72: 173-184.
7. Romagnani S (1995) Biology of human TH1 and TH2 cells. J Clin Immunol 15: 121-129.
8. Raziuddin S, Al-Dalaan A, Bahabri S, Siraj AK, Al-Sedairy S (1998) Divergent cytokine production profile in Behcet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 25: 329-333.
9. Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, et al. (2002) Cytokine profile in Behc¸et's disease patients. Scandinavian journal of rheumatology 31: 205-210.
10. Li B, Yang P, Zhou H, Huang X, Jin H, et al. (2005) Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease. Br J Ophthalmol 89: 1410-1412.
11. Liu X, Yang P, Lin X, Ren X, Zhou H, et al. (2009) Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Clin Immunol 131: 333-342.
12. Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, et al. (2011) Expression of Th-17 and RORγt mRNA in behc¸et's disease. Medical science monitor: international medical journal of experimental and clinical research 17: R227.
13. Wang C, Tian Y, Lei B, Xiao X, Ye Z, et al. (2012) Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 53: 4668-4675.
14. Chi W, Zhu X, Yang P, Liu X, Lin X, et al. (2008) Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci 49: 3058-3064.
15. Oshika T, Nishi M, Mochizuki M, Nakamura M, Kawashima H, et al. (1989) [Quantitative assessment of aqueous flare intensity and cell count in uveitis]. Nihon Ganka Gakkai Zasshi 93: 1032-1037.
16. Weichsler B, Davatchi F, Mizushima Y, Hamza M, Dilsen N, et al. (1990) Criteria for diagnosis of Behc¸et's disease. Lancet 335: 1078-1080.
17. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, et al. (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131: 647-652.
18. Fang W, Zhou H, Yang P, Huang X, Wang L, et al. (2008) Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 92: 182-185.
19. Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, et al. (2012) Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet's disease. Arthritis Res Ther 14: R99.
20. El-Asrar AM, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, et al. (2011) Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol 139: 177-184.
21. Commodaro AG, Peron J, Genre J, Arslanian C, Sanches L, et al. (2010) IL-10 and TGF-β Immunoregulatory Cytokines rather than Natural Regulatory T Cells are Associated with the Resolution Phase of Vogt-Koyanagi-Harada (VKH) Syndrome. Scandinavian journal of immunology 72: 31-37.
22. Akdeniz N, Esrefoglu M, Keles MS, Karakuzu A, Atasoy M (2004) Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. ANNALS-ACADEMY OF MEDICINE SINGAPORE 33: 596-599.
23. Misumi M, Hagiwara E, Takeno M, Takeda Y, Inoue Y, et al. (2003) Cytokine production profile in patients with Behcet's disease treated with infliximab. Cytokine 24: 210-218.
24. Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators Inflamm 11: 87-93.
25. de Boer JH, Van Haren M, de Vries-Knoppert W, Baarsma GS, De Jong P, et al. (1992) Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes. Current eye research 11: 181-186.
26. Caspi RR, Chan CC, Grubbs BG, Silver PB, Wiggert B, et al. (1994) Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J Immunol 152: 890-899.
27. Matsuoka K, Inoue N, Sato T, Okamoto S, Hisamatsu T, et al. (2004) T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut 53: 1303-1308.